EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The role of NLRC5 in human inflammatory bowel diseases and murine experimental colitis

Brian P Fay iD, Jason Tam, John A Wrobel, Guannan Huang, Wei-Chun Emily Chou, Shehzad Z Sheikh, Terrence S Furey iD, Ryan Balfour Sartor, Hao Guo, Jenny P-Y Ting

The Journal of Immunology · 02.11.2026 · 215 (11)

DOI: 10.1093/jimmun/vkag263 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Immunology, online erschienen am 06.11.2026. Verfasst von Brian P Fay und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. Hauptthemen laut MEDLINE: Intracellular Signaling Peptides and Proteins, Colitis, Inflammatory Bowel Diseases. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nucleotide-binding, leucine-rich repeat-containing (NLR) innate immune proteins have been implicated in inflammatory bowel diseases (IBD). NLRC5 is a key trans-activator of class I MHC (MHC-I) genes, but it is also found to regulate cytokines and cell death. Meta-analysis of 14 different human RNAseq or microarray data (total n = 1,093) revealed a consistent and strong association between IBD and heightened NLRC5 expression, suggesting a role for NLRC5 across diverse IBD patients. Furthermore, these data show a strong correlation of NLRC5 with inflammation and STAT1 signatures, suggesting that its role in human IBD may extend beyond its canonical role as a regulator of MHC-I, or that its expression is controlled by inflammation/STAT1. However, in the dextran sulfate sodium (DSS)-induced colitis mouse model, Nlrc5 protected against colitis, which mimicked B2m−/− mice lacking MHC-I. This Nlrc5-associated protection has been consistent across hundreds of mice over a decade in the hands of several investigators. Microbiome study found significant alterations in the microbiota in overall composition and strain-specific differences over time, suggesting a dynamic relationship between microbiome dysbiosis and Nlrc5. To resolve these issues, we studied germ-free (GF) wild-type and Nlrc5−/− mice. Surprisingly, GF mice showed that Nlrc5 exacerbated instead of protected against DSS-induced colitis. A major difference between GF and conventionally-raised mice is that DSS reduced Nlrc5/ 2m expression in GF mice, while it did the opposite in SPF mice. These data highlight the complex role of Nlrc5 and the microbiome in the pathogenesis of IBD, as well as the necessity of complementary mouse models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intracellular Signaling Peptides and ProteinsColitisInflammatory Bowel DiseasesAnimalsHumansMiceDisease Models, AnimalGastrointestinal MicrobiomeMice, Knockout

Stichwörter der Autor:innen

IBDNLRC5colitismicrobiome

Substanzen

Intracellular Signaling Peptides and ProteinsNLRC5 protein, humanNLRC5 protein, mouse

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Center for Translational Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.

ORCID-Profile: Brian P Fay, Terrence S Furey

Förderung

  • NIDDK NIH HHS
  • NIH HHS
  • NCI NIH HHS
  • NIH/NIDDK
  • P40 OD010995
  • UNC-ITCMS
  • Crohn's and Colitis Foundation

Zitieren

APA

Fay, B. P., Tam, J., Wrobel, J. A., Huang, G., Chou, W. E., Sheikh, S. Z., Furey, T. S., Sartor, R. B., Guo, H., & Ting, J. P. (2026). The role of NLRC5 in human inflammatory bowel diseases and murine experimental colitis. The Journal of Immunology, 215(11). https://doi.org/10.1093/jimmun/vkag263

Vancouver

Fay BP, Tam J, Wrobel JA, Huang G, Chou WE, Sheikh SZ, et al. The role of NLRC5 in human inflammatory bowel diseases and murine experimental colitis. The Journal of Immunology. 2026;215(11). doi:10.1093/jimmun/vkag263

BibTeX
@article{Fay2026,
  author = {Fay, Brian P and Tam, Jason and Wrobel, John A and Huang, Guannan and Chou, Wei-Chun Emily and Sheikh, Shehzad Z and Furey, Terrence S and Sartor, Ryan Balfour and Guo, Hao and Ting, Jenny P-Y},
  title = {The role of NLRC5 in human inflammatory bowel diseases and murine experimental colitis},
  journal = {The Journal of Immunology},
  year = {2026},
  volume = {215},
  number = {11},
  doi = {10.1093/jimmun/vkag263}
}
Kostenlos starten →